Published in Eur J Clin Invest on February 01, 1983
Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr (2010) 2.46
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest (2004) 1.67
Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest (1984) 1.33
Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity. J Clin Invest (1987) 1.17
Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III. Am J Clin Nutr (2008) 1.03
Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians. J Clin Invest (1990) 0.87
Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment. Annu Rev Nutr (2015) 0.87
Effect of dietary fat saturation on plasma lipoproteins and high density lipoprotein metabolism of the rhesus monkey. J Clin Invest (1987) 0.81
Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. J Lipid Res (2012) 0.79
Reducing Cholesterol Intake: Are the recommendations valid? Can Fam Physician (1991) 0.75
Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell (2000) 9.99
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02
Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. Nucleic Acids Res (2001) 6.49
The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet (1977) 5.10
Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) (1987) 5.01
Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet (1985) 4.83
Knowledge-based indexing of the medical literature: the Indexing Aid Project. J Am Soc Inf Sci (1987) 4.15
Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil (1993) 3.50
Structural relationships among Rhizobium meliloti symbiotic promoters. Cell (1983) 3.23
Learning of visceral and glandular responses. Science (1969) 3.13
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J (1998) 3.13
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med (1995) 2.89
Interaction between transcription factors Sp1 and YY1. Nature (1993) 2.87
Cytogenetic analysis of a segment of the Y chromosome of Drosophila melanogaster. Genetics (1984) 2.75
HIV infection en route to endogenization: two cases. Clin Microbiol Infect (2014) 2.63
Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science (1990) 2.55
Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A (2001) 2.44
Cimetidine and HDL cholesterol. Lancet (1983) 2.40
Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A (2001) 2.39
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26
Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County. Am J Prev Med (1998) 2.23
Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res (2000) 2.05
Social class, coronary risk factors and undernutrition, a double burden of diseases, in women during transition, in five Indian cities. Int J Cardiol (1999) 2.04
Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet (1985) 1.99
Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. Am J Med (1994) 1.96
An operant approach to rehabilitation medicine: overcoming learned nonuse by shaping. J Exp Anal Behav (1994) 1.96
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Letter: High-density lipoprotein and atherosclerosis. Lancet (1975) 1.93
Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest (1966) 1.88
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J (1992) 1.88
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J (1987) 1.88
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Regulation of macrophage activation. Cell Mol Life Sci (2003) 1.83
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest (1975) 1.82
Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) (1981) 1.80
Intralenticular hemorrhage following blunt ocular trauma. Arch Ophthalmol (1998) 1.78
The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology. Circulation (1996) 1.76
Epidemic perinatal listeriosis. Pediatr Infect Dis (1984) 1.74
Longitudinal surveillance of antibiotic use in the hospital. QJM (2001) 1.69
The prothrombin 20209 C-->T mutation in Jewish-Moroccan Caucasians: molecular analysis of gain-of-function of 3' end processing. J Thromb Haemost (2006) 1.67
BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity (Silver Spring) (2008) 1.64
Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet (1981) 1.61
Prevalence of coronary artery disease and coronary risk factors in rural and urban populations of north India. Eur Heart J (1997) 1.61
Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf) (1995) 1.61
Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts. J Clin Invest (1977) 1.58
Fertilization increases the polyphosphoinositide content of sea urchin eggs. Nature (1984) 1.57
Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest (1980) 1.55
Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) (1990) 1.55
Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord (2001) 1.52
Metabolism of amylobarbitone in patients with chronic liver disease. Br J Pharmacol (1972) 1.50
Serum bile acids in liver disease. Gut (1971) 1.50
Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase. Pathology (1996) 1.49
Newly diagnosed thyrotoxicosis in hospitalized patients: clinical characteristics. QJM (2008) 1.48
Homozygous Tangier disease and cardiovascular disease. Atherosclerosis (1994) 1.48
Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol (2008) 1.48
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res (1975) 1.47
Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci (2000) 1.47
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther (2007) 1.45
Regulation of cortical vesicle exocytosis in sea urchin eggs by inositol 1,4,5-trisphosphate and GTP-binding protein. J Cell Biol (1986) 1.43
Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J R Soc Interface (2009) 1.42
Is povidone-iodine a hemostyptic? A clinical study. Int J Oral Maxillofac Surg (2006) 1.42
Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol (1998) 1.42
The structure of d(CGCGAAT[]TCGCG) . d(CGCGAATTCGCG); the incorporation of a thymine photodimer into a B-DNA helix. Nucleic Acids Res (1984) 1.41
Interactions between learned and physical factors in mental illness. Semin Psychiatry (1972) 1.40
Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci (1996) 1.40
Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol (1995) 1.40
Recurrent ascites in an infant with perinatally acquired cytomegalovirus infection. Eur J Pediatr (1989) 1.39
The value of behavioral research on animals. Am Psychol (1985) 1.38
Nonsteroidal antiinflammatory agents. I. 6-substituted 2-naphthylacetic acids. J Med Chem (1970) 1.38
Psychiatric training for family doctors: what do GP registrars want and can a brief course provide this? Med Educ (1999) 1.37
Differences in body composition of black and white girls. Am J Clin Nutr (1996) 1.36
Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol (2000) 1.35
Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord (2004) 1.34
Free energy perturbation calculations on binding and catalysis after mutating Asn 155 in subtilisin. Nature (1987) 1.33
Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J (1987) 1.33
Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation (2001) 1.32
Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. Eur J Clin Invest (1980) 1.32
Serum-bile-acids in the stagnant-loop syndrome. Lancet (1969) 1.30
Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab (2004) 1.30
Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes. Arthritis Rheum (2001) 1.27
Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease. Arterioscler Thromb Vasc Biol (1999) 1.26
High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man. Lancet (1985) 1.26